The Effect of 12 Lead ECG Telemetry on Reperfusion Time in Resource-limited Settings
NCT ID: NCT02441582
Last Updated: 2018-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2015-07-31
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Different Reperfusion Timing and Ventricular Arrhythmias in STEMI Patients
NCT04660474
Smartphone Twelve Lead Electrocardiogram Utility In ST Elevation Myocardial Infarction
NCT04057404
Contrast ICE for Myocardial Scar in VT Ablations
NCT03212326
Using Heart Electrical Signals to Study How Well Treatments Prevent Dangerous Heart Rhythms in Active People
NCT07014579
AF Stroke Substudy SL-ECG Versus 12lead ECG
NCT03715361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telemetry
In this group, participants will have a prehospital 12 lead ECG taken and sent through to the receiving facility.
Telemetry
Non-Telemetry
In this group, participants will have a prehospital 12 lead ECG taken which will not be sent through to the receiving facility.
Non-telemetry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telemetry
Non-telemetry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients presenting within the Gauteng or Western Cape areas
* Current chest pain or dyspnoea, presumed to be of cardiac origin
* ST-elevation (STEMI) on the ECG (defined as ST-elevation of 0.1 mV in two or more contiguous leads).
Exclusion Criteria
* Chest pain of non-cardiac aetiology (following trauma or due to a primary respiratory pathology)
* Non-consent to inclusion within the study
* Patients without medical aid or who states that they cannot afford private healthcare.
* Non-ST-elevation myocardial infarction
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ER24
UNKNOWN
University of Stellenbosch
OTHER
Philips Healthcare
INDUSTRY
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Willem Stassen
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ER24 Gauteng Region
Johannesburg, Gauteng, South Africa
ER24 Western Cape Region
Cape Town, Western Cape, South Africa
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3-1178/2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.